Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Mastering DataDerm: Leveraging MIPS and Measure Testing for Success
Description
In this presentation, Steve, a past chair of the Performance Measure Committee, discusses the importance of leveraging DataDerm in conjunction with MIPS (Merit-based Incentive Payment System) to improve dermatological care quality and reporting. He encourages dermatologists to join the Performance Measure Committee to help shape future dermatology measures. The talk explores the evolution of quality measurement under MACRA (Medicare Access and CHIP Reauthorization Act) and the transition from MIPS to the new MIPS Value Pathways (MVPS), emphasizing the need for quality improvement through data collection. Steve highlights the challenges dermatologists face in measuring quality due to a lack of straightforward indicators, unlike other specialties. He outlines the different types of MIPS measures available, stressing the added benefit of DataDerm’s unique QCDR measures for dermatologists. He shares best practices for reporting and the significance of establishing benchmarks that are achievable yet meaningful. Steve demonstrates how utilizing DataDerm leads to improved practice performance and patient outcomes through better data insights and quality improvement cycles. Lastly, he notes the exciting future of DataDerm and encourages participation in this free program to enhance dermatological care metrics, thereby contributing to a more comprehensive understanding of dermatology practices in the U.S.
View moreConclusions
- The implementation of MIPS (Merit-based Incentive Payment System) aims to improve the quality of care in dermatology by incentivizing physicians based on their performance.
- DataDerm serves as a Qualified Clinical Data Registry (QCDR) that helps dermatologists collect and report relevant quality measures for MIPS.
- Participating in DataDerm can lead to improved patient outcomes, as evidenced by higher performance rates in quality measures.
- The MIPS 410 measure for psoriasis response indicates a strong performance among participants, demonstrating the potential for effective quality tracking.
- Setting higher benchmarks in performance measures can help maintain the relevance of these metrics in achieving better patient care outcomes.
- Active engagement in quality improvement activities through MIPS can ultimately benefit patient care in dermatology.
- Educational resources and guidance available through the AAD platform can aid dermatologists in navigating MIPS reporting effectively.
- J Am Acad Dermatol. 2023 May;88(5):1119-1121.
- J Psoriasis Psoriatic Arthritis. 2022 Jul;7(3):140-149.
- J Am Acad Dermatol. 2024 May;90(5):1002-1005.
- CMS. MIPS Value Pathways (MVPs). Qpp.cms.gov. https://qpp.cms.gov/mips/mips-value-pathways
- CMS. MIPS Value Pathways Diagram-1. Qpp.cms.gov. https://qpp.cms.gov/mips/mips-value-pathways